Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 11.23
+0.47 (4.37%)
At close: Mar 12, 2026
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 3.81 billion as of March 12, 2026. Its market cap has decreased by -60.31% in one year.
Market Cap
3.81B
Enterprise Value
4.29B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
11.23
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 3.81B, an increase of 2,402.96%. That is a compound annual growth rate of 47.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 3.81B | 0.29% |
| Dec 31, 2025 | 3.79B | -53.94% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 2.83B |
| Neuren Pharmaceuticals | 1.59B |
| Clarity Pharmaceuticals | 1.47B |
| PYC Therapeutics | 1.47B |
| Opthea | 738.77M |
| Immutep | 582.12M |
| Clinuvel Pharmaceuticals | 503.51M |
| Racura Oncology | 428.87M |